Bridging Intensity Is Associated with Impaired Hematopoietic Recovery following BCMA CAR-T Therapy for Multiple Myeloma

In this multicenter international observational study, researchers explored the impact of bridging therapy on hematopoietic reconstitution in 158 patients with relapsed/refractory multiple myeloma treated with B-cell maturation antigen-directed CAR T-cell therapy.